
NEOGENOMICS INC
Nasdaq · Services-Testing Laboratories
Company Overview
A concise company profile alongside the latest public filing activity.
NeoGenomics operates clinical laboratories that provide cancer-focused genetic and molecular testing services, including diagnostic, prognostic, and predictive tests used by oncologists, pathologists, and pharmaceutical companies to guide cancer diagnosis and treatment decisions.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
| Member | Chamber | Type | Amount | Date |
|---|---|---|---|---|
| Gilbert CisnerosCA31 | House | Buy | $1,001 - $15,000 | Aug 7, 2026 |
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable NEO activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.